Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A to Z of Drugs : T

Records returned : 175 (on 16 Jul 2025 at 17:57:13).

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Status :
Blue
Formulations :
  • Capsules
  • Modified release capsules
  • Modified release tablets
  • Tablets
Restrictions / Comments:

Important

For EXISTING patients: GPs may continue to prescribe for existing post-transplant patients only. NHS England are looking to repatriate these patients in the future. GPs must not accept any new requests to prescribe for new patients.

 
Links :
NHSE
SPC
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important

For NEW patients: RED drug for post-transplant. Funded by NHS England. GPs should not accept any requests to prescribe post-transplant.

 
Links :
NHSE
SPC
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
NFD1
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred

Sildenafil is 1st line.

Tadalafil 10mg / 20mg for when-required dosing.

Tadalafil 5mg (once daily option)

2.5mg tadalafil (once dilay) is non-formulary.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • 2.5mg ONCE DAILY
Restrictions / Comments:

Important
Once daily tadalafil 2.5mg is non-formulary. Sildenafil is 1st line. Tadalafil (10mg, 20mg or 5mg) is an alternative.
 
Links :
Status :
Non Formulary
Formulations :
  • ONCE DAILY
  • Tablets
Restrictions / Comments:

 
Links :
NFD1
SPC
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important

2.5mg tablets are non-formulary (very costly)

 
Links :
SPC
Indication :
Status :
Non Formulary
Formulations :
  • 2.5mg ONCE DAILY
Restrictions / Comments:

Important
2.5mg tablets are non-formulary (very costly)
 
Links :
NFD1
SPC
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important

SASH only - under shared care agreement with tertiary centre.

 
Links :
R
SPC
Status :
Blue
Formulations :
  • Eye drops (preservative free)
Restrictions / Comments:

Important
Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care
 
Links :
Indication :
Status :
Red
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Not Specified
Restrictions / Comments:

Important

1st month supply from specialist team before request for primary care prescribing

 
Links :
Status :
Blue
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

Important

Specialist initiation and prescribing for at least 1 month before any request is made for primary care prescribing.

 
Links :
Indication :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important

Off-label use. Gynaecomastia prevention in men undergoing long-term bicalutamide treatment, if radiotherapy unsuccessful

 
Links :
SPC
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
NFD1
SPC
Status :
Green
Formulations :
  • Modified release capsules
Restrictions / Comments:

Preferred
 
Links :
SPC
Status :
Non Formulary
Formulations :
  • Modified release tablets
Restrictions / Comments:

Important
Use modified release capsules
 
Links :
NFD1
SPC
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
NFD1
SPC
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
Off Label
SPC
Indication :
Status :
Red
Formulations :
  • Capsules
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
NHSE Specialised Commissioning. Not currently commissioned from ASPH, RSFT or SASH
 
Links :
NHSE
NICE
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Follow local guidelines on the use of antimicrobials. This drug requires Therapeutic Drug Monitoring.
 
Links :
R
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important

Non-formulary for new patients, but current patients may continue

 
Links :
NHSE
NICE
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
 
Links :
R
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
Indication :
Status :
Red
Formulations :
  • Intravenous injection (IV)
Restrictions / Comments:

Important
10,000 unit injection - licensed for acute MI
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Granules
  • Tablets
Restrictions / Comments:

Important

RESTRICTED - requires Hepatologist Specialist approval

 
Links :
NHSE
NICE
R
SPC
29. Tentrini
Drug:
Tentrini
(Paediatric enteral feeds)
Status :
Blue
Formulations :
  • Liquid
Restrictions / Comments:

Important

Enteral feeds should NOT be prescribed in primary care in Guildford and Waverley or North West Surrey. In Surrey Downs and East Surrey prescribe on request from specialist dietitian 

 
Links :
30. Tentrini Energy
Drug:
Tentrini Energy
(Paediatric enteral feeds)
Status :
Blue
Formulations :
  • Liquid
Restrictions / Comments:

Important

Enteral feeds should NOT be prescribed in primary care in Guildford and Waverley or North West Surrey. In Surrey Downs and East Surrey prescribe on request from specialist dietitian 

 
Links :
Status :
Blue
Formulations :
  • Liquid
Restrictions / Comments:

Important

Enteral feeds should NOT be prescribed in primary care in Guildford and Waverley or North West Surrey. In Surrey Downs and East Surrey prescribe on request from specailist dietitian 

 
Links :
32. Tentrini Multifibre
Drug:
Tentrini Multifibre
(Paediatric enteral feeds)
Status :
Blue
Formulations :
  • Liquid
Restrictions / Comments:

Important

Enteral feeds should NOT be prescribed in primary care in Guildford and Waverley or North West Surrey. In Surrey Downs and East Surrey prescribe on request from specialist dietitian 

 
Links :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important

Restricted for patients with renal or hepatic failure

 
Links :
R
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Alternative low carbon DPI (Easyhaler Salbutamol is the more cost-effective treatment option)

Prescribe by BRAND.

 
Links :
Status :
Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Alternative low carbon DPI (Easyhaler Salbutamol is the more cost-effective treatment option)

Prescribe by BRAND.

 
Links :
Indication :
Status :
Blue
Formulations :
  • Nebules
Restrictions / Comments:

Important

Specialist* recommendation following patient initiation and education on nebuliser therapy.

* a healthcare professional with higher training in respiratory medicine and proficeincy in the management of asthma

 
Links :
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
Severe acute asthma
 
Links :
Status :
Blue
Formulations :
  • Nebules
Restrictions / Comments:

Important

Specialist recommendation following patient initiation and education on nebuliser therapy

 
Links :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important

Severe acute asthma

 
Links :
Status :
Red
Formulations :
  • Infusion
Restrictions / Comments:

Important
Under specialist supervision in hospital
 
Links :
R
SPC
Indication :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
NHSE
NICE
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important

Post-menopausal osteoporosis in women. Rheumatology only. 
See separate entry for use in men and juveniles.
Biosimilar teriparatide is recommended. Prescribe by brand.

 
Links :
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important

RSFT only  - commissioned as a Specialised Endocrinology Centre.

See separate entry for use in postmenopausal osteoporosis.

 
Links :
NHSE
R
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
SPC
Status :
Blue
Formulations :
  • Intramuscular injection (IM)
Restrictions / Comments:

Important

Off-label use. Initiation and review by the specialist team before any request is made for primary care prescribing.

Sustanon (Testosterone esters / testosterone propionate / testosterone decanoate)

 
Links :
Off Label
SPC
Status :
Blue
Formulations :
  • Intramuscular injection (IM)
Restrictions / Comments:

Important

Off-label use. Initiation and review by the specialist team before any request is made for primary care prescribing.

Testosterone enantate

 
Links :
Off Label
SPC
Status :
Blue
Formulations :
  • Gel
Restrictions / Comments:

Important

Off-label use. Initiation and review by the specialist team before any request is made for primary care prescribing.

Tostran gel - SASH - use in smaller children with neuromuscular conditions who need a more gentle induction.
Off-label use

 
Links :
Off Label
SPC
Status :
Blue
Formulations :
  • Intramuscular injection (IM)
Restrictions / Comments:

Important

Off-label use. Initiation and review by the specialist team before any request is made for primary care prescribing.

Testosterone propionate (unlicensed product)

 
Links :
SPC
Status :
Green
Formulations :
  • Gel
Restrictions / Comments:

Important

Prescribe generically as "Testosterone 2% transdermal gel 60g".

See PAD for further information and resources.

 
Links :
Off Label
SPC
Status :
Non Formulary
Formulations :
  • Gel
Restrictions / Comments:

Important

Testavan and Testogel do NOT deliver suitable doses for this indication

Prescribe as testosterone 2% transdermal gel (off-label use)

 
Links :
NFD1
SPC
Status :
Non Formulary
Formulations :
  • Cream
Restrictions / Comments:

Important

Androfeme is unlicensed in the UK. Other products can be used off-label

 
Links :
NFD1
SPC
Indication :
Status :
Blue
Formulations :
  • Intramuscular injection (IM)
Restrictions / Comments:

Important

Initiation in primary care on request from specialist team.

Sustanon (Testosterone esters / testosterone propionate / testosterone decanoate)

 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Intramuscular injection (IM)
Restrictions / Comments:

Important

Initiation in primary care on request from specialist team.

Nebido (testosterone undecanoate)

 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Intramuscular injection (IM)
Restrictions / Comments:

Important

Initiation in primary care on request from specialist team.

Testosterone enantate

 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Gel
Restrictions / Comments:

Important

Initiation in primary care on request from specialist team.

Testavan, Testogel, Tostran - prescribe by brand to avoid errors and confusion. Multiple doses and delivery methods (sachets, pumps, tubes).

 
Links :
SPC
Status :
Amber
Formulations :
  • Gel
  • Injection
Restrictions / Comments:

 
Links :
Guidelines
Off Label
SPC
Status :
Amber
Formulations :
  • Gel
  • Injection
Restrictions / Comments:

 
Links :
Guidelines
Off Label
SPC
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important

Includes choreas, Huntington's chorea, dyskinesia, hemiballismus

 
Links :
SPC
Status :
Red
Formulations :
  • Eye drops (preservative free
  • unit dose)
Restrictions / Comments:

Important
0.5% and 1% preservative free eye drops
 
Links :
SPC
Status :
Red
Formulations :
  • Depot injection
  • Intravenous injection (IV)
Restrictions / Comments:

Important

IV injection - 30 minute diagnostic test
IM injection - 5 hour diagnostic test

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
NHSE Specialist Commissioned Services only
 
Links :
NHSE
SPC
Indication :
Status :
Non Formulary
Restrictions / Comments:

Important
on formulary for other non-infection indications
 
Links :
NFD2
SPC
Indication :
Status :
Blue
Formulations :
  • Eye drops
Restrictions / Comments:

Important
Severe dry eye
Prescribe by brand. Prescribe on specialist recommendation
 
Links :
Indication :
Status :
See narrative
Formulations :
  • Modified release tablets
Restrictions / Comments:

Important
Place in therapy under review. Therapeutic drug monitoring required. Not recommended for primary care initiation without specialist advice.
 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important

Prevention of Wericnicke's encephalopathy

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Solution for injection
Restrictions / Comments:

Important

Second line to vitamins B + C intravenous high potency concentrate solution for infusion 

 
Links :
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important

For supplementation in cases of concern regarding deficiency post-surgery.

 
Links :
Indication :
Status :
Blue
Formulations :
  • Powder
Restrictions / Comments:

Important

On advice from speech and language therapist only 

 
Links :
Indication :
Status :
Blue
Formulations :
  • Powder
Restrictions / Comments:

Important

For infants following ketogenic diet on advice of paediatric speech and language therapist only

 
Links :
Status :
Red
Formulations :
  • Intramuscular injection (IM)
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Non Formulary
Restrictions / Comments:

 
Links :
NFD1
SPC
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
NFD1
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Prescribe generically
 
Links :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
Clopidogrel is the preferred option. Specialist initiation and at least one month supply before transfer to primary care
 
Links :
Status :
Blue
Formulations :
  • Oro-dispersible tablets
Restrictions / Comments:

Important
Clopidogrel is the preferred option. Specialist initiation and at least one month supply before transfer to primary care
Reserve for use in patients with swallowing difficulties.
 
Links :
Indication :
Status :
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Infusion
Restrictions / Comments:

Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
 
Links :
R
SPC
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
ICB
NICE
SPC
Status :
Blue
Formulations :
  • Eye drops
Restrictions / Comments:

Important
0.25% and 0.5% eye drops. Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care.
 
Links :
Status :
Blue
Formulations :
  • Eye gel
Restrictions / Comments:

Important
0.25% and 0.5% gel-forming solution (Timoptol-LA) Initiation by specialist team before transfer of prescribing to primary care.
 
Links :
Status :
Blue
Formulations :
  • Eye drops (preservative free
  • unit dose)
Restrictions / Comments:

Important
0.1% (1mg/g) preservative free eye gel. Once daily use. Initiation by specialist team before transfer of prescribing to primary care.
 
Links :
Indication :
Status :
Red
Formulations :
  • Eye drops
Restrictions / Comments:

Important
Restricted to use in infants only
 
Links :
R
SPC
Indication :
Status :
Red
Restrictions / Comments:

 
Links :
SPC
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

 
Links :
SPC
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

 
Links :
SPC
Status :
Blue
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important
Specialist initiation and at least one month supply before transfer to primary care (excluding obstetric and cancer patients).
 
Links :
SPC
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important
Off-label use.
 
Links :
Off Label
SPC
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Safety concerns with device. Combination of LAMA and LABA recommended in COPD.

Not for initiation in new patients.

 
Links :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Expensive device, no advantage over other LAMAs, and combination with LABA recommended in COPD.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Green
Formulations :
  • Soft mist inhaler
Restrictions / Comments:

Important

Only LAMA licensed in asthma.

Prescribe by BRAND.

 
Links :
Status :
Green
Formulations :
  • Soft mist inhaler
Restrictions / Comments:

Important

Combination with LABA recommended in COPD.

Prescribe by BRAND.

 
Links :
Status :
Green
Formulations :
  • Soft mist inhaler
Restrictions / Comments:

 
Links :
Indication :
Status :
Red
Restrictions / Comments:

Important
Restricted Antimicrobial - requires GUM Specialist approval
 
Links :
NHSE
R
SPC
Status :
Red
Formulations :
  • Intravenous infusion
Restrictions / Comments:

Important
Restricted to cardiology consultants
 
Links :
SPC
98. Tirzepatide
Drug:
Tirzepatide
(Antidiabetic drugs)
Indication :
Status :
Green (see narrative)
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important
Dulaglutide is the preferred weekly injection. Semaglutide is an alternative for weekly injections. Tirzepatide is 3rd line where dulaglutide / semaglutide are unsuitable or unavailable.
 
Links :
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important
Access through the specialist weight management service at Ashford & St Peters NHS Foundation Trust ONLY
 
Links :
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Intramuscular injection (IM)
Restrictions / Comments:

Important

Not recommended under NICE TA971

 
Links :
NFD1
NICE
SPC
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
Specialist to retain prescribing for first 4 months. Monitor liver function.
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Inhalation
Restrictions / Comments:

 
Links :
NHSE
SPC
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Specialist centres only
 
Links :
NHSE
SPC
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Specialist centres only
 
Links :
NHSE
SPC
Indication :
Status :
Red
Formulations :
  • Infusion
Restrictions / Comments:

 
Links :
Indication :
Status :
Red
Formulations :
  • Intravenous infusion
Restrictions / Comments:

Important
Severe disease only
 
Links :
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Specialist centres only
 
Links :
NHSE
SPC
Status :
Red
Formulations :
  • Tablets
  • Tablets (slow release)
Restrictions / Comments:

Important
For use in ankylosing spondylitis only
 
Links :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important
Ulcerative colitis - adults only
 
Links :
Indication :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
ICB
NICE
SPC
Indication :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important
Severe disease only
 
Links :
112. Tolbutamide
Drug:
Tolbutamide
(Antidiabetic drugs)
Indication :
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
Amber
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Status :
Green (see narrative)
Formulations :
  • Immediate release tablets
Restrictions / Comments:

Important
1st line in patients with renal impairment
 
Links :
Status :
Non Formulary
Formulations :
  • Modified release tablets
Restrictions / Comments:

Important

Switch to solifenacin (or formulary alternative) recommended

 
Links :
Status :
See narrative
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important

NHSE specialised commissioning - RSFT only

 
Links :
R
SPC
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important

Prescribing by nephrologists only.

 
Links :
Indication :
Status :
Blue
Formulations :
  • Capsules
  • Oral suspension
  • Tablets
Restrictions / Comments:

Important
Pregnancy Prevention Plan required for females of childbearing potential.
Capsules (Sprinkle) reserved for use in patients who cannot swallow tablets. Liquid reserved for patients who cannot swallow tablets or capsules
 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Pregnancy Prevention Plan required for females of childbearing potential.
 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Capsules
Restrictions / Comments:

Important
Pregnancy Prevention Plan required for females of childbearing potential.
Capsules (Sprinkle) reserved for use in patients who cannot swallow tablets.
 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Oral suspension
Restrictions / Comments:

Important
Pregnancy Prevention Plan required for females of childbearing potential.
Only use where patient cannot swallow tablets or capsules (sprinkle) are not suitable.
 
Links :
Indication :
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Capsules
Restrictions / Comments:

Important
Consider use where maximum tolerated doses of codeine / dihydrocodeine are ineffective.
 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Modified release capsules
  • Modified release tablets
Restrictions / Comments:

Important
Branded prescribing is recommended for modified release tramadol. Do not confuse 12 hourly and 24 hourly preparations. Consider tramadol where maximum tolerated doses of codeine / dihydrocodeine are ineffective.
 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Soluble tablets
Restrictions / Comments:

Important
Reserved for patients unable to swallow solid dose forms or for administration via an enteral tube. Consider use where maximum tolerated doses of codeine / dihydrocodeine are ineffective.
 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Oro-dispersible tablets
Restrictions / Comments:

Important
Reserved for patients unable to swallow solid dose forms or for administration via an enteral tube. Consider use where maximum tolerated doses of codeine / dihydrocodeine are ineffective.
 
Links :
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Oral solution
Restrictions / Comments:

 
Links :
Guidelines
CD
NFD1
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Oral drops
Restrictions / Comments:

 
Links :
Guidelines
CD
NFD1
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Capsules
  • Soluble tablets
Restrictions / Comments:

Important
NICE CG 173 Consider tramadol only if acute rescue therapy is needed. Prescribe a short course (2-4 weeks on an acute script) and review at least every 3 months.
 
Links :
CD
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Modified release capsules
  • Modified release tablets
Restrictions / Comments:

Important
NICE CG 173 Consider tramadol only if acute rescue therapy is needed. Prescribe a short course (2-4 weeks on an acute script) and review at least every 3 months.
MR preparations to be prescribed by brand. Marol MR tablets are the locally preferred brand for primary care.
 
Links :
CD
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
Guidelines
CD
NFD1
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Includes menorrhagia, epistaxis and local fibrinolysis
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
Includes menorrhagia, epistaxis and local fibrinolysis
 
Links :
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Capsules
Restrictions / Comments:

Important
Includes menorrhagia, epistaxis and local fibrinolysis
 
Links :
NFD1
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
short term prophylaxis
 
Links :
SPC
Status :
Red
Formulations :
  • Mouthwash
  • Soluble tablets
Restrictions / Comments:

Important
5% mouthwash - unlicensed product. Used in line with St Luke's SACT protocols
 
Links :
SPC
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important
SASH - Tablets used to make a mouthwash (off-label use). Use in line with St Luke's SACT protocols
 
Links :
Off Label
SPC
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
Initiation and stabilisation by specialist for a minimum of 6 months before transfer of prescribing to primary care.
 
Links :
Status :
Blue
Formulations :
  • Eye drops
Restrictions / Comments:

Important
Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care
 
Links :
Status :
Blue
Formulations :
  • Eye drops
Restrictions / Comments:

Important
Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care
 
Links :
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
NHS England - specialist centres only
 
Links :
NHSE
SPC
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important

NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.

 
Links :
NFD1
NHSE
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Nasal spray
Restrictions / Comments:

Important

Mometasone Furoate 50mcg/dose (140 dose container) is the preferred intranasal steroid for allergic rhinitis. Triamcinolone is considered to be a 3rd / 4th line agent.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
Indication :
Status :
Red
Formulations :
  • Intravitreal injection
Restrictions / Comments:

Important

 

 

40mg/ml preservative free ophthalmic suspension (Intracinol brand). Unlicensed.

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Subtenon / Optical floor injection
Restrictions / Comments:

Important

 

 

RSCH: use Kenalog for subtenon / orbital floor injections. Off-label use.

 
Links :
Off Label
SPC
Status :
Red
Formulations :
  • Intracameral injection
  • Intravitreal injection
Restrictions / Comments:

Important

Intracinol 40mg/mL Preservative Free Ophthalmic Suspension (Medical Device). Unlucensed.

 
Links :
SPC
Status :
Green
Formulations :
  • Intra-articular injection
Restrictions / Comments:

 
Links :
SPC
Status :
Green
Formulations :
  • Intra-articular injection
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Capsules
  • Tablets
Restrictions / Comments:

Important

Use only by a Wilson's specialist, with input from a specialist teriary centre.

 
Links :
R
SPC
Status :
Blue
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

Important

Initiation by a SABP specialist and stabilisation for at least 3 months before any request to transfer prescribing responsibility.

 
Links :
SPC
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important

Procyclidine tablets are the preferred treatment option.

SABP specialist initiation and stabilisation for at least one month before any request for transfer of prescribing responsibility.

Antimuscarinics should not be used in tardive dyskinesia

Recommendation for use to be made by SABP specialist only after consideration and trial of reduction of antipsychotic dose has occured or alternative treatment options have first been tried.
See PAD for additional safety advice.

 
Links :
SPC
Status :
Blue
Formulations :
  • Oral solution
Restrictions / Comments:

Important

SABP specialist initiation and stabilisation for at least one month before any request for transfer of prescribing responsibility.

Tablets are the preferred treatment option. Reserve oral solution for patients unable to swallow the tablets.

Recommendation for use to be made by SABP specialist only after consideration and trial of reduction of antipsychotic dose has occured or alternative treatment options have first been tried.

See PAD for additional safety information.

 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

Important

Paediatrics only. Transfer to primary care only after initiation and stabilisation.

 
Links :
Off Label
SPC
Status :
Blue
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

Important
Off-label use. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team
 
Links :
Guidelines
Off Label
SPC
Status :
Blue
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

Important
Off-label use. 2nd-line option in children over 3 years. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team
 
Links :
Guidelines
Off Label
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
NFD1
SPC
Indication :
Status :
Green
Formulations :
  • Oral suspension
  • Tablets
Restrictions / Comments:

Important
Follow local guidelines on the use of antimicrobials.
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Amber
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Injection
Restrictions / Comments:

Important

Primary Care prescribing appropriate on recommendation from the specialist team.

 
Links :
SPC
Status :
Amber
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
Guidelines
Off Label
SPC
Status :
Amber
Formulations :
  • Injection
Restrictions / Comments:

Important

EXISTING patients only. Do not initiate in new patients.

 
Links :
Guidelines
Off Label
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Eye drops (preservative free
  • unit dose)
Restrictions / Comments:

Important
0.5% and 1% unit dose eye drops
 
Links :
SPC
Status :
Green (see narrative)
Formulations :
  • Immediate release tablets
Restrictions / Comments:

Important
Alternative 1st line in patients where anticholinergic burden is a problem or on medicines that interact.
 
Links :
Status :
Green (see narrative)
Formulations :
  • Modified release tablets
Restrictions / Comments:

Important
2nd line in patients where anticholinergic burden is a problem or on medicines that interact.
 
Links :
Status :
See narrative
Formulations :
  • Capsules
Restrictions / Comments:

Important

This drug has not yet been assessed for formulary status. Contact your pharmacy team for advice on making an application to APC.

 
Links :
NFD2
SPC
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important

NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.

 
Links :
NFD1
NHSE
SPC
175. Twocal RTH
Drug:
Twocal RTH
(Adult enteral feeds)
Status :
Blue
Formulations :
  • Liquid
Restrictions / Comments:

Important

Enteral feeds should NOT be prescribed in primary care in Guildford and Waverley or North West Surrey. In Surrey Downs and East Surrey prescribe on request from specialist dietitian 

 
Links :